Abstract

Acquisition of JAK2 V617F to CALR-mutated clones accelerates disease progression and might enhance growth capacity.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Clinical importance of different calreticulin gene mutation types in wild-type JAK2 essential thrombocythemia and myelofibrosis patients.
C Sun ... J.-Y Li
Haematologica | VOL. 99
C Sun, et. al.C Sun ... J.-Y Li
11 Jul 2014
Cytokine profiles in polycythemia vera and essential thrombocythemia patients: Clinical implications
Pascal Mossuz ... Emmanuel Pourcelot
Experimental Hematology | VOL. 42
Pascal Mossuz, et. al.Pascal Mossuz ... Emmanuel Pourcelot
23 Jan 2014
Abstract 37: An unusual case of myelofibrosis with a JAK2 H538QK539L mutation associated with nephrotic syndrome
Moon Ley Tung ... Hersharan Kaur Sran
Clinical Cancer Research | VOL. 23
Moon Ley Tung, et. al.Moon Ley Tung ... Hersharan Kaur Sran
14 Dec 2017
Low JAK2 V617F Allele Burden in Ph-Negative Chronic Myeloproliferative Neoplasms Is Associated with Additional CALR or MPL Gene Mutations
Elena E Stepanova ... Irina N Subortseva
Genes | VOL. 12
Elena E Stepanova, et. al.Elena E Stepanova ... Irina N Subortseva
12 Apr 2021
View more papers

More From: British journal of haematology

Paper Title
Journal
Date
Author
Recurrent ETV6::SYK rearrangement in myeloid malignancies confers partial susceptibility to MEK inhibition.
Karen Manuelyan ... Velizar Shivarov
British journal of haematology | VOL. -
Karen Manuelyan, et. al.Karen Manuelyan ... Velizar Shivarov
19 May 2024
Mixed histiocytic disorders: Nature versus nurture?
Kenneth Mcclain ... Peter Dimitrion
British journal of haematology | VOL. -
Kenneth Mcclain, et. al.Kenneth Mcclain ... Peter Dimitrion
19 May 2024
Considerations for anti-PD1-based first-line treatment of Hodgkin lymphoma.
Paul J Bröckelmann
British journal of haematology | VOL. -
Paul J BröckelmannPaul J Bröckelmann
16 May 2024
A case of de novo -α3.7 thalassaemia and the utility of CATSA for detecting de novo mutations in thalassaemia.
Lei Zhang ... Weiqing Wu
British journal of haematology | VOL. -
Lei Zhang, et. al.Lei Zhang ... Weiqing Wu
16 May 2024
View more papers